Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

GSK PLC GSK shares inched up 0.03% to £14.97 Thursday, on what proved to be an all-around favorable trading session for the ...

Check the time stamp on this data. Updated AI-Generated Signals for Gsk Plc American Depositary Shares (each Representing Two ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

GSK has announced a £50m ($54.3m) investment in a new partnership with the University of Cambridge and Cambridge University ...

The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...

Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...